Issue navigation
Volume 74, Issue 5, May 2019
Review
Pharmacokinetic considerations regarding the treatment of bacterial sexually transmitted infections with azithromycin: a review
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1157–1166, https://doi.org/10.1093/jac/dky548
For debate
Is selective decontamination (SDD/SOD) safe in the ICU context?
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1167–1172, https://doi.org/10.1093/jac/dky573
Systematic review
Effectiveness of interventions involving pharmacists on antibiotic prescribing by general practitioners: a systematic review and meta-analysis
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1173–1181, https://doi.org/10.1093/jac/dky572
Original research
Truncation of GdpP mediates β-lactam resistance in clinical isolates of Staphylococcus aureus
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1182–1191, https://doi.org/10.1093/jac/dkz013
The chloramphenicol/H+ antiporter CraA of Acinetobacter baumannii AYE reveals a broad substrate specificity
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1192–1201, https://doi.org/10.1093/jac/dkz024
CMY-1/MOX-family AmpC β-lactamases MOX-1, MOX-2 and MOX-9 were mobilized independently from three Aeromonas species
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1202–1206, https://doi.org/10.1093/jac/dkz025
Occurrence and characterization of Escherichia coli ST410 co-harbouring blaNDM-5, blaCMY-42 and blaTEM-190 in a dog from the UK
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1207–1211, https://doi.org/10.1093/jac/dkz017
ChloS-HRM, a novel assay to identify chloramphenicol-susceptible Escherichia coli and Klebsiella pneumoniae in Malawi
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1212–1217, https://doi.org/10.1093/jac/dky563
Convergence of virulence and MDR in a single plasmid vector in MDR Klebsiella pneumoniae ST15
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1218–1222, https://doi.org/10.1093/jac/dkz028
Genomic analysis of Klebsiella pneumoniae isolates from Malawi reveals acquisition of multiple ESBL determinants across diverse lineages
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1223–1232, https://doi.org/10.1093/jac/dkz032
Whole genome assembly and functional portrait of hypervirulent extensively drug-resistant NDM-1 and KPC-2 co-producing Klebsiella pneumoniae of capsular serotype K2 and ST86
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1233–1240, https://doi.org/10.1093/jac/dkz023
Ceftazidime/avibactam resistance associated with L169P mutation in the omega loop of KPC-2
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1241–1243, https://doi.org/10.1093/jac/dkz026
High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1244–1252, https://doi.org/10.1093/jac/dkz030
Prevalence of the crpP gene conferring decreased ciprofloxacin susceptibility in enterobacterial clinical isolates from Mexican hospitals
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1253–1259, https://doi.org/10.1093/jac/dky562
Emergence of clonal fluconazole-resistant Candida parapsilosis clinical isolates in a multicentre laboratory-based surveillance study in India
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1260–1268, https://doi.org/10.1093/jac/dkz029
Stable isotope labelling: an approach for MALDI-TOF MS-based rapid detection of fluconazole resistance in Candida tropicalis
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1269–1276, https://doi.org/10.1093/jac/dkz019
Eradication of persister cells of Acinetobacter baumannii through combination of colistin and amikacin antibiotics
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1277–1283, https://doi.org/10.1093/jac/dkz034
Evaluation of the RESIST-4 K-SeT assay, a multiplex immunochromatographic assay for the rapid detection of OXA-48-like, KPC, VIM and NDM carbapenemases
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1284–1287, https://doi.org/10.1093/jac/dkz031
Novel external quality assurance scheme for drug susceptibility testing of non-tuberculous mycobacteria: a multicentre pilot study
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1288–1294, https://doi.org/10.1093/jac/dkz027
In vitro activity of APX001A against rare moulds using EUCAST and CLSI methodologies
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1295–1299, https://doi.org/10.1093/jac/dkz022
In vitro activity of oritavancin alone or in combination against vancomycin-susceptible and -resistant enterococci
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1300–1305, https://doi.org/10.1093/jac/dkz010
Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1306–1310, https://doi.org/10.1093/jac/dkz006
Evaluation of apramycin against spectinomycin-resistant and -susceptible strains of Neisseria gonorrhoeae
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1311–1316, https://doi.org/10.1093/jac/dkz012
Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1317–1322, https://doi.org/10.1093/jac/dkz018
Temocillin breakpoints in pyelonephritis: evaluation in a murine model due to ESBL-producing Escherichia coli clinical isolates
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1323–1326, https://doi.org/10.1093/jac/dky569
Efficacy of T-2307, a novel arylamidine, against ocular complications of disseminated candidiasis in mice
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1327–1332, https://doi.org/10.1093/jac/dkz020
Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1333–1341, https://doi.org/10.1093/jac/dky560
Pharmacokinetics of cefazolin delivery via the cardiopulmonary bypass circuit priming solution in infants and children
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1342–1347, https://doi.org/10.1093/jac/dky574
Evaluating darunavir/ritonavir dosing regimens for HIV-positive pregnant women using semi-mechanistic pharmacokinetic modelling
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1348–1356, https://doi.org/10.1093/jac/dky567
Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1357–1362, https://doi.org/10.1093/jac/dkz007
Durability of first-line regimens including integrase strand transfer inhibitors (INSTIs): data from a real-life setting
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1363–1367, https://doi.org/10.1093/jac/dky566
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1368–1375, https://doi.org/10.1093/jac/dkz021
Dolutegravir plus lamivudine for initial treatment of HIV-1-infected participants with HIV-1 RNA <500 000 copies/mL: week 48 outcomes from ACTG 5353
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1376–1380, https://doi.org/10.1093/jac/dky564
Inflammation status in HIV-positive individuals correlates with changes in bone tissue quality after initiation of ART
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1381–1388, https://doi.org/10.1093/jac/dkz014
Anti-gp41 antibody levels reflect HIV viral suppression and cellular reservoir in long-term antiretroviral-treated trial participants
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1389–1394, https://doi.org/10.1093/jac/dkz004
Emtricitabine triphosphate in dried blood spots is a predictor of viral suppression in HIV infection and reflects short-term adherence to antiretroviral therapy
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1395–1401, https://doi.org/10.1093/jac/dky559
Baseline PI susceptibility by HIV-1 Gag-protease phenotyping and subsequent virological suppression with PI-based second-line ART in Nigeria
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1402–1407, https://doi.org/10.1093/jac/dkz005
Detection of pretreatment minority HIV-1 reverse transcriptase inhibitor-resistant variants by ultra-deep sequencing has a limited impact on virological outcomes
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1408–1416, https://doi.org/10.1093/jac/dky561
Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1417–1424, https://doi.org/10.1093/jac/dkz011
Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1425–1429, https://doi.org/10.1093/jac/dky558
Oral fosfomycin for the treatment of chronic bacterial prostatitis
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1430–1437, https://doi.org/10.1093/jac/dkz015
Implementation of a pharmacist-led penicillin allergy de-labelling service in a public hospital
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1438–1446, https://doi.org/10.1093/jac/dky575
Antibiotic prescribing for residents in long-term-care facilities across the UK
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1447–1451, https://doi.org/10.1093/jac/dkz008
Research letters
Genomic characterization of inpatient evolution of MRSA resistant to daptomycin, vancomycin and ceftaroline
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1452–1454, https://doi.org/10.1093/jac/dkz003
Evaluation of the OXA-23 K-SeT® immunochromatographic assay for the rapid detection of OXA-23-like carbapenemase-producing Acinetobacter spp
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1455–1457, https://doi.org/10.1093/jac/dkz001
In vitro synergistic activity of meropenem/vaborbactam in combination with ceftazidime/avibactam against KPC-producing Klebsiella pneumoniae
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1457–1459, https://doi.org/10.1093/jac/dky557
Temocillin plasma and pancreatic tissue concentrations in a critically ill patient with septic shock
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1459–1461, https://doi.org/10.1093/jac/dky565
Virological efficacy of dual therapy with lamivudine and dolutegravir in HIV-1-infected virologically suppressed patients: long-term data from clinical practice
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1461–1463, https://doi.org/10.1093/jac/dkz009
Letter to the Editor
Comment on: Improving access to appropriate post-exposure doxycycline for Lyme disease prophylaxis: role for community pharmacies
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Pages 1464–1465, https://doi.org/10.1093/jac/dky570
Erratum
Pharmacokinetics of dolutegravir with and without darunavir/cobicistat in healthy volunteers
Journal of Antimicrobial Chemotherapy, Volume 74, Issue 5, May 2019, Page 1466, https://doi.org/10.1093/jac/dky571
